Business Description
SpectraCure AB
ISIN : SE0007158118
Compare
Compare
Traded in other countries / regions
SPEC.Sweden2OK.Germany IPO Date
2019-02-08Description
SpectraCure AB develops treatment planning and laser light dose management for cancer treatment. The Company has developed its software IDOSE, and medical laser devices for the treatment.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 7.4 | |||||
| Equity-to-Asset | 0.88 | |||||
| Debt-to-Equity | 0.05 | |||||
| Debt-to-EBITDA | -0.35 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -10.5 | |||||
| 3-Year EPS without NRI Growth Rate | -7.5 | |||||
| 3-Year FCF Growth Rate | -19.9 | |||||
| 3-Year Book Growth Rate | -13 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 58.57 | |||||
| 9-Day RSI | 53.81 | |||||
| 14-Day RSI | 51.42 | |||||
| 6-1 Month Momentum % | -40.69 | |||||
| 12-1 Month Momentum % | -63.05 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.82 | |||||
| Quick Ratio | 3.82 | |||||
| Cash Ratio | 3.61 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -1.8 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -15.63 | |||||
| ROA % | -14.08 | |||||
| ROIC % | -25.14 | |||||
| ROC (Joel Greenblatt) % | -312.15 | |||||
| ROCE % | -14.88 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.87 | |||||
| Price-to-Tangible-Book | 6.07 | |||||
| EV-to-EBIT | -9.24 | |||||
| EV-to-EBITDA | -10.27 | |||||
| EV-to-FCF | -5.94 | |||||
| Price-to-Net-Current-Asset-Value | 6.07 | |||||
| Price-to-Net-Cash | 9.1 | |||||
| Earnings Yield (Greenblatt) % | -10.82 | |||||
| FCF Yield % | -13.81 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
SpectraCure AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.018 | ||
| Beta | 0.81 | ||
| Volatility % | 53.94 | ||
| 14-Day RSI | 51.42 | ||
| 14-Day ATR (€) | 0.011455 | ||
| 20-Day SMA (€) | 0.17575 | ||
| 12-1 Month Momentum % | -63.05 | ||
| 52-Week Range (€) | 0.1492 - 0.492 | ||
| Shares Outstanding (Mil) | 97.13 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
SpectraCure AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
SpectraCure AB Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
SpectraCure AB Frequently Asked Questions
What is SpectraCure AB(FRA:2OK)'s stock price today?
The current price of FRA:2OK is €0.18. The 52 week high of FRA:2OK is €0.49 and 52 week low is €0.15.
When is next earnings date of SpectraCure AB(FRA:2OK)?
The next earnings date of SpectraCure AB(FRA:2OK) is 2024-08-15.
Does SpectraCure AB(FRA:2OK) pay dividends? If so, how much?
SpectraCure AB(FRA:2OK) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers